This is the authors' abstract. We don't add key points for this paper.
Following mantle-field irradiation for Hodgkin's disease, patients experience a transient acute pulmonary reaction resulting in a decreased vital capacity and forced expiratory volume. This reaction begins 2-3 months after the start of therapy, reaching a maximum intensity at 4-6 months and subsiding by about 8 months. In patients with intrathoracic disease, the improvement following tumor regression may result in a net increase in pulmonary function following treatment.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sagerman et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: